Posted on 03/20/2020 5:46:44 PM PDT by foundedonpurpose
MUST SEE: Chloroquine Already Used on Coronavirus in US Study Shows 100% Success Rate And May Act as Preventative to Virus (VIDEO)
Women System March 20, 2020 2 Comments 0 comment
Dr. Mihael Polymeropoulos, the co-founder and former CEO of Vanda Pharmaceuticals, joined Tucker Carlson on Thursday night to discuss the use of chloroquine in the treatment of coronavirus. On Monday Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, reported that the anti-viral medication chloroquine is showing success in fighting the coronavirus. ** An Effective Treatment for Coronavirus (COVID-19) Dr. Gregory Rigano, the co-author of the study, later went on with Laura Ingraham and then Tucker Carlson to discuss the results from the chloroquine study. Dr. Rigano announced that their study found that COVID-19 patients who took hydroxy-chloroquine were found free of the disease in 6 days. The patients were testing negative for the coronavirus in six days! Dr. Rigano also said taking choroquine could act as a preventative. On Wednesday night Dr. Rigano told Tucker Carlson that a new peer-reviewed study out of France found that chloroquine had a 100% success rate in treating patients with coronavirus.
(Excerpt) Read more at womensystems.com ...
I think this is the same malaria pills they gave us in Vietnam.
I mean in general, buy stock.
In engineering school I was taught that any sample of 13 or more was considered to be "statistically significant".
His cousin is the renowned tailor, Yannis Polyesteropoulos.
Quinine treatment has been tried on about every disease known to mankind over the past hundreds of years.
Thats the bottom line. The right to try law.In this case - since the med is Generally Regarded As Safe (GRAS), it shouldnt require that you be at deaths door for you to have a right to try it.
Always assuming that supply isnt denied to people who are at deaths door.
Bookmarked!
Almost every lupus patient in the USA takes Chloroquine daily.
Why not do a quick study where all of these lupus patients take a COVID-19 test? See what the incidence of infection is.
That would answer the question with a huge study patient count.
Australia is reporting success with it
Its pretty clear that his agenda includes protecting his bureaus turf. That is inevitable.If he is replaced... There will be no tears from me.
Since it is inevitable that his agenda includes protecting his bureaus turf, anyone from the top of his bureaucracy would have the same agenda.Therefore, replacing him with someone better from that agency is a fools errand. Fauci is acceptable, and useful, where he is. For now.
After this is over there will be time to evaluate bureaucratic incentives and performance. Not now. If hindsight shows that the experimental use of the drug was the best thing since sliced bread, that will be a PR problem for Fauci and his agency as a whole.
I wonder if fauci would take it if he started showing symptoms?
Little sh!t is probably on it preventively after hitting the talk show circuit (CNN,Today Show ect).
Ping
The bottom line is both anti malaria pills they are taking about now for the virus have been proven safe by thousands of military. Whether they are effective against the virus or not is irrelevant on my opinion. Try the damn stuff! They didn't know if they worked as a malaria preventative in those days either.
I seem to recall that those who ran the study explained that they were not able to randomize the groups in the study. Also, they lost six from the treatment group, three of whom were very seriously ill. The group which experienced 100% success consisted of only six people.
Finally, the group of six who were successfully "cured" were treated with both hydroxychloroquine AND azithromycin. The group that was treated with only hydroxychloroquine experienced, if I recall correctly, only 57% success.
Given the lack of properly randomized treatment and control groups, I don't understand how those who did the study came up with the probability calculations they published. I see the study as having many of the shortcomings of anecdotal evidence.
That would be very interesting, wouldn't it? I can see some challenges.
It has been suggested that perhaps 85% of people get the virus and have no symptoms. Nationally, I think we are at 300k COVID-19 patients. Assume then that we actually have 1.8M patients.
Assume lupus affects 50 per 100k people in the U.S. and that all of them take chloroquine. That would be 150k people with lupus in the country.
These numbers might mean that one person in 1000 in the U.S. has COVID-19. That might mean that there would be 150 lupus patients with COVID-19.
Now comes the hard part. How do we sample the lupus patients in order to draw conclusions about how protected they are? If lupus patients are 50% protected, then there would actually be around 75 lupus patients with COVID-19. How many would we have to sample and what results would we have to get in order to conclude one way or the other?
One detail is that not every state has the same number of COVID-19 patients. If we don't take that into account and simply choose lupus patients at random throughout the U.S., then we risk getting a result showing good effect simply because we oversampled states with no or little COVID-19.
I'm sure that an actual study would have even more complications.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.